Virbac : ROCc FY 2023 un peu au-dessus du Css – Perspectives confirmées
>ROCc à 15,1% vs « autour de 15% » guidé - Le ROC contributif se monte à 188,1 M€, soit +0,8% et 15,1% du CA (15,3% à tcc.). Le RN affiche est stable à 121 M€ (Css : 124 M€e), impacté par les devises et la hausse des taux (plus importants que prévu pour nous). A fin 2023, le cash net ressort à 52 M€ (ie. après un programme de rachat d’actions à hauteur de 20 M€ et les acquisitions de GS Partners et Globion, mais avant prise en compte du rachat de Sasaeah dont la VE at...Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.